Fresenius Kabi Usa, Llc: Lidocaine Hcl Injection, Usp, 2%, 100 Mg Per
Lidocaine HCl Injection Recall Summary Fresenius Kabi is recalling Lidocaine HCl Injection 2% (100 mg per 5 mL vials) because hair was found in some products. The affected vials were distributed nationwide to healthcare facilities and pharmacies. This is a Class II recall, meaning use of the product could cause serious adverse health effects or death.
- Recalling firm
- Fresenius Kabi USA, LLC
- Product
- Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-208-05; NDC Vial: 63323-208-01
- Reason
- Presence of Particulate Matter: Hair was found in products
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-16
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/3a86647a-329d-4c46-8717-32e026bab089